MRS

Inducing short to medium neuroplastic effects with Transcranial Ultrasound Stimulation

Sound waves can be used to modify brain activity safely and transiently with unprecedented precision even deep in the brain - unlike traditional brain stimulation methods. In a series of studies in humans and non-human primates, I will show that Transcranial Ultrasound Stimulation (TUS) can have medium- to long-lasting effects. Multiple read-outs allow us to conclude that TUS can perturb neuronal tissues up to 2h after intervention, including changes in local and distributed brain network configurations, behavioural changes, task-related neuronal changes and chemical changes in the sonicated focal volume. Combined with multiple neuroimaging techniques (resting state functional Magnetic Resonance Imaging [rsfMRI], Spectroscopy [MRS] and task-related fMRI changes), this talk will focus on recent human TUS studies.

From function to cognition: New spectroscopic tools for studying brain neurochemistry in-vivo

In this seminar, I will present new methods in magnetic resonance spectroscopy (MRS) we’ve been working on in the lab. The talk will be divided into two parts. In the first, I will talk about neurochemical changes we observe in glutamate and GABA during various paradigms, including simple motors tasks and reinforcement learning. In the second part, I’ll present a new approach to MRS that focuses on measuring the relaxation times (T1, T2) of metabolites, which reflect changes to specific cellular microenvironments. I will explain why these can be exciting markers for studying several in-vivo pathologies, and also present some preliminary data from a cohort of mild cognitive impairment (MCI) patients, showing changes that correlate to cognitive decline.

The pharmacology of consciousness

My research uses a range of methods to better understand how the brain’s natural chemicals control complex behaviours, thoughts and perceptions. I also have a particular fascination about the factors that determine the contents of an individual’s conscious experience. In this talk I will present work that sits at the intersection of these two research areas looking at the role of different neurotransmitter systems in driving changes in conscious state. Specifically, I will discuss a series of studies using ambiguous stimuli to explore the neuropharmacological processes that underly alternations in perceptual awareness. By comparing different methods and neurotransmitter systems including: serotonin (psychedelics), noradrenaline (pupillometry) and Glutamate/GABA (Magnetic Resonance Spectroscopy MRS) we can start to tease apart the distinct role that different neurotransmitter systems play in coordinating conscious experience across time.

Understanding sensorimotor control at global and local scales

The brain is remarkably flexible, and appears to instantly reconfigure its processing depending on what’s needed to solve a task at hand: fMRI studies indicate that distal brain areas appear to fluidly couple and decouple with one another depending on behavioral context. But the structural architecture of the brain is comprised of long-range axonal projections that are relatively fixed by adulthood. How does the global dynamism evident in fMRI recordings manifest at a cellular level? To bridge the gap between the activity of single neurons and cortex-wide networks, we correlated electrophysiological recordings of individual neurons in primary visual (V1) and retrosplenial (RSP) associational cortex with activity across dorsal cortex, recorded simultaneously using widefield calcium imaging. We found that individual neurons in both cortical areas independently engaged in different distributed cortical networks depending on the animal’s behavioral state, suggesting that locomotion puts cortex into a more sensory driven mode relevant for navigation.

Effects of the chronic treatment with an A2A/A2B receptor mixed agonist, MRS3997, on cerebral injury in a rat model of transient brain ischemia

A qualitative analysis of the relationship of glutamate and glutamine and metabolic profiling in focal epilepsy using 7T CRT-FID-MRSI

FENS Forum 2024